CLINICAL_TRIALS
trial_result
· 2011-09-26
Clinical Trial Update: Safety and Efficacy Study of CF101 to Treat Psoriasis [Phase 2]
Summary
Phase 2 clinical trial evaluating CF101 for safety and efficacy in treating plaque psoriasis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Can-Fite BioPharma | Conditions: Plaque Psoriasis | Phase 2 | Status: COMPLETED | Results posted: 2011-09-26